Skip to main content
Home
  • About
    • About the Navigator
    • Navigator FAQs
  • Guides
    • For Patients and Caregivers
    • For Physicians and Healthcare Providers
    • For Companies and Sponsors
  • Company Directory
    • View Company Directory
    • Submit Company Information
  • Resources
  • Expanded Access eRequest
  • facebook
  • twitter
  • linkedin
  • youtube
Home
  • About
    • About the Navigator
    • Navigator FAQs
  • Guides
    • For Patients and Caregivers
    • For Physicians and Healthcare Providers
    • For Companies and Sponsors
  • Company Directory
    • View Company Directory
    • Submit Company Information
  • Resources
  • Expanded Access eRequest

Impact of COVID19 on Asthma

  • Read more about Impact of COVID19 on Asthma

Self-Management Interventions for Long COVID-19

  • Read more about Self-Management Interventions for Long COVID-19

Vaccine Responses to SARS-CoV-2 and Other Emerging Infectious Diseases

  • Read more about Vaccine Responses to SARS-CoV-2 and Other Emerging Infectious Diseases

The Standard of Care Combined With Glucocorticoid in Elderly People With Mild or Moderate COVID-19

  • Read more about The Standard of Care Combined With Glucocorticoid in Elderly People With Mild or Moderate COVID-19

Study on Sequential Immunization of Omicron Inactivated COVID-19 Vaccine and Prototype Inactivated COVID-19 Vaccine in Population Aged 18 Years Old and Above

  • Read more about Study on Sequential Immunization of Omicron Inactivated COVID-19 Vaccine and Prototype Inactivated COVID-19 Vaccine in Population Aged 18 Years Old and Above

Analysis of Breathing Pattern Post COVID-19

  • Read more about Analysis of Breathing Pattern Post COVID-19

Allogenic UCMSCs as Adjuvant Therapy for Severe COVID-19 Patients

  • Read more about Allogenic UCMSCs as Adjuvant Therapy for Severe COVID-19 Patients

A Study to Evaluate the Safety and Immunogenicity of Omicron COVID-19 Vaccine (Vero Cell), Inactivated in Population 18 Years Old of Age and Above

  • Read more about A Study to Evaluate the Safety and Immunogenicity of Omicron COVID-19 Vaccine (Vero Cell), Inactivated in Population 18 Years Old of Age and Above

Immunogenicity and Safety of an Inactivated SARS-CoV-2 Vaccine Coadministered With Two Attenuated Vaccines

  • Read more about Immunogenicity and Safety of an Inactivated SARS-CoV-2 Vaccine Coadministered With Two Attenuated Vaccines

The Impact of Covid 19 Pandemic on Ureteric Stents Complications.

  • Read more about The Impact of Covid 19 Pandemic on Ureteric Stents Complications.

Pagination

  • First page « First
  • Previous page ‹ Previous
  • …
  • Page 97
  • Page 98
  • Page 99
  • Page 100
  • Current page 101
  • Page 102
  • Page 103
  • Page 104
  • Page 105
  • …
  • Next page Next ›
  • Last page Last »
Subscribe to

Subscribe for updates from the Reagan-Udall Foundation for the FDA

Subscribe
(202) 849 - 2075
1333 New Hampshire Ave, NW
Suite 420
Washington, DC 20036
navigator@reaganudall.org
  • facebook
  • twitter
  • linkedin
  • youtube

© Reagan-Udall Foundation for the FDA
© Reagan-Udall Foundation for the FDA